Sample banner

Veteran medical research scientist and public health expert Dr. Yeri Israel Kombe has been appointed as the Acting Chief Executive Officer and Director of the Kenya Medical Research Institute (KEMRI).

Dr. Kombe who takes over from Dr. Gerald Mkoji who has been acting in a similar position since December 2015.

In a letter dated 28th March 2017 addressed to Dr. Kombe, the Cabinet Secretary of Health, Dr. Cleopa Mailu informed that the appointment was with effect from 1st April, 2017.

Dr. Kombe is not new in KEMRI. He is the immediate National Coordinator of the Food Handlers Programme and a former Center Director of the Center for Public Health Research (CPHR) where he served for over six years.

Dr. Kombe is also an accomplished researcher who has participated in a number studies that have contributed immensely to public health policies in the country. He is also a trainer and mentor of many young scientists not only in Kenya, but also throughout the region.

As he assumed his seat, Dr. Kombe was quick to thank his predecessor, Dr. Mkoji for “his selfless service and competent leadership he has offered to this Institute for the last one and half years” and wished him well as he proceeds for his leave and retirement.

Also joining KEMRI alongside Dr. Kombe is Mr. Kamau Mugenda as the Deputy Director in charge of Administration and Finance.

Sample image

Mr. Mugenda brings into KEMRI over 25 years work experience in Finance, Administration, Human Resource Management.

Before taking up his new position after a competitive recruitment process, Mugenda was working with the National Oil Corporation of Kenya as General Manager in charge of Finance and Administration under whose docket included Finance, Human Resources, Administration, ICT, Safety, Health, Environment and Quality Departments.

He previously he was the Finance Manager at the Corporation before being promoted the General Manager’s position. Other positions held include in the past were Group Internal Audit Manager, Head of Finance, Group Chief Accountant among other positions while at the Kenol Kobil Limited.

Mr. Mugenda holds a Master’s in Business Administration - (Finance option) from the University of Nairobi, Bachelor of Science in International Business Administration from the United States International University.

He is a Certified Accountant and a member of the Institute of Certified Public Accountants of Kenya and has attended many short courses on management, both locally and internationally.

Sample image

The Kenya Medical Research Institute has donated eight automatic soap dispensers and hand sanitizers to Nairobi Primary School as part of its Corporate Social Responsibility activities with the aim to reduce risks of infectious diseases among pupils.

Approximately 1,800 pupils will benefit from the hand sanitizers mounted at strategic places like the washrooms and dining hall areas in a bid to enhance personal hygiene and general sanitation within the school environment.


Sample image

The KEMRI Board of Management has appointed Dr. Yeri Kombe to the position of Director and Chief Executive Officer, of the Kenya Medical Research Institute (KEMRI) for a two years term with effect from 1st March 2018.

In a letter dated 6th March 2018 to all staff, the Board of Management Chairman, Dr. Naphtali Agata said “On my own behalf and on behalf of the KEMRI Board of Management, I take this opportunity to congratulate Dr. Kombe on his appointment.


For over 20 years, KEMRI researchers have advocated the use of Insecticide treated bed nets in Malaria endemic areas as part of combined strategies in dealing with Malaria. This is with registered success in malaria reduction in Western and Coast regions among other areas in Kenya.

KEMRI is conducting a study seeking to improve the half-life of the natural pyrethrins using nanotechnology so that they can be used for bed nets instead of pyrethroids.

Most industrialized countries are phasing out the use of synthetic pyrethroids and replacing them with other alternatives including using natural pyrethrins.

The challenge is that pyrethrins have very short half-life hence has not been used in the insecticide treated nets.

It is against this background that we wish to clarify that although pyrethroids are generally known to be harmful, the levels of concentrations when used in manufacturing bed nets are completely safe and strictly adhere to World Health Organizations (WHO) guidelines.

We therefore wish to clarify that insecticide treated nets are safe for use and consequently allay any possible fears that may have been raised by the media.

Corporate Affairs Department

The KEMRI – Defense Threat Reduction Agency (DTRA)/Cooperative Biological Engagement Program (CBEP) Collaborative Project was informed by an agreement signed during the visit to Kenya by the former United States of America (USA) President, Barack Obama, between his government and the Government of Kenya (GOK) concerning Cooperation in Threat Reduction Biological Engagement Programs.

This collaborative engagement will see the construction of a Sample Management and Receiving Facility (SMRF) building, the construction of a two-storey office connector building and the construction of two, two-story multi-purpose conference rooms.

It also involves the purchase, installation, and commissioning of two new biomedical waste incinerators; installation of three new insectaries; renovations of selected laboratory and office spaces; training and capacity building of KEMRI personnel in line with biosafety, biosecurity and the provision of Pathogen Asset Control System (PACS) and capacity building to operate and utilize the system for sample management.

As a national institution responsible for conducting human health research in Kenya and with a mandate to provide solutions for health problems affecting the Kenyan public, KEMRI’s mandate includes the isolation, handling, storage and discarding of proliferative dangerous pathogens (biological) and the handling of dangerous chemicals used in research affecting human life.

At the moment, preparations and designs of the agreed construction and renovations of the selected laboratory and office space is not only complete, but also agreed upon by the two parties; KEMRI and DTRA.

It is against this background that the DTRA team paid a courtesy call to Director KEMRI on Tuesday, May 2nd, 2017 to finalize on arrangements to begin the project, expected to begin before the end of this May 2017.

 

loader

Upcoming Events

Feb
13

02.13.2019 - 02.15.2019

Ceremony of Signature of Covention between KEMRI & Oita University

Sample image


Director KEMRI Dr. Yeri Kombe, and President of Oita University Prof. Segio Kitano, signs Memorandum of Understanding between the two institutions.

In the agreement KEMRI & Oita staff and students will work together on research in Cancer starting with Stomach Cancer in Kenya.

 

KEMRI Renews MOU with Nagasaki University

Sample image


Dr. Yeri Kombe, Director, KEMRI exchange documents with Prof. Shigeru Kohno, President of Nagasaki University, in Japan shortly after the two renewed the Memorandum of Understanding between the two institutions.

Dr. Kombe and Prof Elijah Songok, Ag. Deputy Director Graduate School of Health Science are in Japan to renew collaborative agreements with various universities in Japan among them Nagasaki, Oita and Kanazawa.

 

KEMRI on Twitter

KEMRI on Facebook

Research Programmes

  • Biotechnology. jpg.jpg
  • Infectious and Parasitic Disease.jpg.jpg
  • natural products.jpg
  • Non- Communicable.jpg
  • Public Health and Health Systems jpg.jpg
  • Sexual, Reproductive, Adolesent & Child Health. jp.jpg

KEMRI has six (6) Main Programmes aligned to the KEMRI Strategic Master plan and the Vision 2030.

Upcoming Events

Sample image


The 12th Annual NTD Conference Conference, scheduled for Dec 5th-7th, 2018, Nairobi, Kenya.

Fight Against HIV



Prof. Matilu Mwau, Director CIPDCR KEMRI discussing on the fight against HIV on KTN.

DNA Testing Lab

Sample image


KEMRI Human DNA Identification Laboratory offers DNA testing services in the area of family relationship testing and Forensic DNA Testing. Read More